KR
53
5
ITW
61
3
APD
57
2
A
40
4
MCO
78
4
NI
60
2
BA
42
-2
SO
68
2
DOV
75
3
PRU
47
5
HBI
37
-2
TROW
50
2
NTRS
39
2
LEG
28
4
MKC
33
-2
PG
60
2
BF.B
48
-3
EQR
64
2
PLD
61
-2
VZ
24
5
KR
53
5
ITW
61
3
APD
57
2
A
40
4
MCO
78
4
NI
60
2
BA
42
-2
SO
68
2
DOV
75
3
PRU
47
5
HBI
37
-2
TROW
50
2
NTRS
39
2
LEG
28
4
MKC
33
-2
PG
60
2
BF.B
48
-3
EQR
64
2
PLD
61
-2
VZ
24
5
Financhill
Back

Royal Gold Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
49

RGLD
Royal Gold

Last Price:
122.04
Seasonality Move:
9.41%
Sell
35

RARE
Ultragenyx Pharmaceutical

Last Price:
37.44
Seasonality Move:
3.65%
Sell
49
Royal Gold (RGLD) is a Sell

Is Royal Gold a Buy, Sell or Hold?

  • The current Royal Gold [RGLD] share price is $121.98. The Score for RGLD is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • RGLD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $37.42. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RGLD Stock Price Chart

What is Royal Gold's stock price today?

  • The Royal Gold share price today is $121.98
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGLD is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $37.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

RGLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.25 Sell
Relative Strength Index (14 RSI): 41.59 Sell
Chaikin Money Flow: 99817 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (123.39 - 131.43) Sell
Bollinger Bands (100): (110.53 - 126.71) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.58 Sell
Relative Strength Index (14 RSI): 37.74 Sell
Chaikin Money Flow: -836354 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.26 - 42.36) Sell
Bollinger Bands (100): (41.26 - 48.86) Sell

RGLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 122.23 Sell
20-day SMA: 126.47 Sell
50-day SMA: 125.07 Sell
200-day SMA: 116.03 Buy
8-day EMA: 122.84 Sell
20-day EMA: 124.84 Sell
50-day EMA: 124.01 Sell
200-day EMA: 118.83 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.11 Sell
20-day SMA: 40.61 Sell
50-day SMA: 42.43 Sell
200-day SMA: 42.45 Sell
8-day EMA: 40.32 Sell
20-day EMA: 40.92 Sell
50-day EMA: 42.29 Sell
200-day EMA: 43.55 Sell

Royal Gold Earnings Growth & RGLD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.10 per share, an increase this year of $1.05 per share, and an increase next year of $1.21 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Royal Gold Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):